Recognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD

International Journal of COPD

Volumn 12, Issue , 2017, Pages 639-650

  Ouellette, Daniel R ^a   Lavoie, Kim L ^b  

^a HENRY FORD HOSPITAL   (United States)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Anxiety disorders; Cognitive impairment; COPD; Hypoxemia; Mood disorders; Pulmonary rehabilitation

Indexed keywords

FORMOTEROL; ROFLUMILAST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE; AMNESIA; BIPOLAR DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE BEHAVIORAL THERAPY; COHORT ANALYSIS; CONTINUOUS OXYGEN THERAPY; DELIRIUM; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOWN SYNDROME; DRUG EFFICACY; DRY POWDER INHALER; DYSTHYMIA; ELECTROENCEPHALOGRAPHY; EXERCISE; GENERALIZED ANXIETY DISORDER; HUMAN; LONGITUDINAL STUDY; MAJOR DEPRESSION; METERED DOSE INHALER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; NOCTURNAL OXYGEN THERAPY; NONHUMAN; NONVERBAL MEMORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; OXYGEN SATURATION; OXYGEN THERAPY; PANIC; POSTTRAUMATIC STRESS DISORDER; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SOCIAL PHOBIA; SYSTEMATIC REVIEW (TOPIC); TACTUAL PERFORMANCE TEST; TELEMEDICINE; TRAIL MAKING TEST; TREATMENT OUTCOME; VERBAL MEMORY TEST; WECHSLER ADULT INTELLIGENCE SCALE; AFFECT; ANXIETY; COGNITION; COGNITION DISORDERS; DEPRESSION; DISEASE COURSE; LUNG; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AFFECT; ANXIETY; COGNITION; COGNITION DISORDERS; DEPRESSION; DISEASE PROGRESSION; HUMANS; LUNG; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TREATMENT OUTCOME;

EID: 85014544112     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S123994     Document Type: Review

References (140)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ. 2002; 51: 1–16.
2. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004; 364 (9434): 613–620.
3. National Heart, Lung, and Blood Institute. Data fact sheet. Chronic obstructive pulmonary disease. Available from: http://www.apsfa.org/docs/copd_fact.pdf. Accessed June 6, 2016.
4. Public Health Agency of Canada. Chronic Pulmonary Obstructive Disease (COPD). Ottawa: Public Health Agency of Canada. Available from: http://www.phac-aspc.Gc.ca/cd-mc/publications/copd-mpoc/ff-rr-2011-eng.php. Accessed March 24, 2016.
5. Cdc.gov. Centers for Disease Control and Prevention. National Center for Health Statistics. Data brief 63: Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998–2009. Available from: http://www.cdc.gov/nchs/data/databriefs/db63_tables.pdf#2. Accessed March 4, 2016.
6. U.S. Department of Health and Human Services. The health benefits of smoking cessation. U.S. Department of Health and Human Services, public health service, centers for disease control, center for chronic disease prevention and health promotion, office on smoking and health. DHHS publication no. (CDC) 90-8416; 1990. Available from: https://profiles.nlm.nih.gov/NN/B/B/C/T/. Accessed June 6, 2016.
7. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176 (6): 532–555.
8. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008; 32 (4): 962–969.
9. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008; 31 (1): 204–212.
10. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser permanente medical care program. Chest. 2005; 128 (4): 2068–2075.
11. Brody JS, Spira A. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc. 2006; 3 (6): 535–537.
12. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009; 34 (2): 380–386.
13. Marquis K, Maltais F, Duguay V, et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2005; 25 (4): 226–232; discussion 233–234.
14. Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009; 136 (4): 1039–1046.
15. Biskobing DM. COPD and osteoporosis. Chest. 2002; 121 (2): 609–620.
16. Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study. Chest. 2009; 136 (6): 1456–1465.
17. Parappil A, Depczynski B, Collett P, Marks GB. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology. 2010; 15 (6): 918–922.
18. Barr RG, Celli BR, Mannino DM, et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med. 2009; 122 (4): 348–355.
19. Anderson D, Macnee W. Targeted treatment in COPD: a multi-system approach for a multi-system disease. Int J Chron Obstruct Pulmon Dis. 2009; 4: 321–335.
20. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010; 35 (4): 913–922.
21. Schou L, Ostergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K. Cognitive dysfunction in patients with chronic obstructive pulmonary disease-a systematic review. Respir Med. 2012; 106 (8): 1071–1081.
22. Guerrero A, Piasecki M. Problem-Based Behavioral Science and Psychiatry. New York, NY: Springer; 2008.
23. Torpy JM, Burke AE, Glass RM. Jama patient page. Delirium. JAMA. 2010; 304 (7): 814.
24. Torpy JM, Lynm C, Glass RM. Jama patient page. Dementia. JAMA. 2008; 300 (19): 2330.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). 2013; Available from: https://goo.gl/X6zEGJ. Accessed July 22, 2016.
26. Schacter DL. Memory, amnesia, and frontal lobe dysfunction. Psychobiology. 1987; 15 (1): 21–36.
27. Torpy JM, Lynm C, Glass RM. Jama patient page. Mild cognitive impairment. JAMA. 2008; 300 (13): 1610.
28. Feldman HH, Jacova C. Mild cognitive impairment. Am J Geriatr Psychiatry. 2005; 13 (8): 645–655.
29. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet. 2006; 367 (9518): 1262–1270.
30. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2001; 56 (9): 1133–1142.
31. Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriat. 2004; 16 (2): 129–140.
32. Antonelli-Incalzi R, Corsonello A, Pedone C, et al. Drawing impairment predicts mortality in severe COPD. Chest. 2006; 130 (6): 1687–1694.
33. Martinez CH, Richardson CR, Han MK, Cigolle CT. Chronic obstructive pulmonary disease, cognitive impairment, and development of disability: the health and retirement study. Ann Am Thorac Soc. 2014; 11 (9): 1362–1370.
34. Villeneuve S, Pepin V, Rahayel S, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012; 142 (6): 1516–1523.
35. Ozge C, Ozge A, Unal O. Cognitive and functional deterioration in patients with severe COPD. Behav Neurol. 2006; 17 (2): 121–130.
36. Dal Negro RW, Bonadiman L, Tognella S, Bricolo FP, Turco P. Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values. Int J Chron Obstruct Pulmon Dis. 2014; 9: 675–683.
37. Liao KM, Ho CH, Ko SC, Li CY. Increased risk of dementia in patients with chronic obstructive pulmonary disease. Medicine (Baltimore). 2015; 94 (23): e930.
38. Fioravanti M, Nacca D, Amati S, Buckley AE, Bisetti A. Chronic obstructive pulmonary disease and associated patterns of memory decline. Dementia. 1995; 6 (1): 39–48.
39. Incalzil RA, Bellia V, Maggi S, et al. Mild to moderate chronic airways disease does not carry an excess risk of cognitive dysfunction. Aging Clin Exp Res. 2002; 14 (5): 395–401.
40. Isoaho R, Puolijoki H, Huhti E, Laippala P, Kivela SL. Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr. 1996; 8 (1): 113–125.
41. Liesker JJ, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med. 2004; 98 (4): 351–356.
42. Rusanen M, Ngandu T, Laatikainen T, Tuomilehto J, Soininen H, Kivipelto M. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. Curr Alzheimer Res. 2013; 10 (5): 549–555.
43. Singh B, Mielke MM, Parsaik AK, et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014; 71 (5): 581–588.
44. Tulek B, Atalay NB, Yildirim G, Kanat F, Suerdem M. Cognitive function in chronic obstructive pulmonary disease: relationship to global initiative for chronic obstructive lung disease 2011 categories. Respirology. 2014; 19 (6): 873–880.
45. Etnier J, Johnston R, Dagenbach D, Pollard RJ, Rejeski WJ, Berry M. The relationships among pulmonary function, aerobic fitness, and cognitive functioning in older COPD patients. Chest. 1999; 116 (4): 953–960.
46. Zhou G, Liu J, Sun F, et al. Association of chronic obstructive pulmonary disease with cognitive decline in very elderly men. Dement Geriatr Cogn Dis Extra. 2012; 2: 219–228.
47. Ortapamuk H, Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med. 2006; 20 (2): 99–106.
48. Zheng GQ, Wang Y, Wang XT. Chronic hypoxia-hypercapnia influences cognitive function: a possible new model of cognitive dysfunction in chronic obstructive pulmonary disease. Med Hypotheses. 2008; 71 (1): 111–113.
49. Antonelli-Incalzi R, Corsonello A, Trojano L, et al. Screening of cognitive impairment in chronic obstructive pulmonary disease. Dement Geriatr Cogn Disord. 2007; 23 (4): 264–270.
50. Crisan AF, Oancea C, Timar B, Fira-Mladinescu O, Crisan A, Tudorache V. Cognitive impairment in chronic obstructive pulmonary disease. PLoS One. 2014; 9 (7): e102468.
51. Park SK, Larson JL. Cognitive function as measured by trail making test in patients with COPD. West J Nurs Res. 2015; 37 (2): 236–256.
52. Prigatano GP, Parsons O, Wright E, Levin DC, Hawryluk G. Neuropsychological test performance in mildly hypoxemic patients with chronic obstructive pulmonary disease. J Consult Clin Psychol. 1983; 51 (1): 108–116.
53. Verma N, Beretvas SN, Pascual B, Masdeu JC, Markey MK; Alzheimer’s Disease Neuroimaging Initiative. New scoring methodology improves the sensitivity of the Alzheimer’s disease assessment scale-cognitive subscale (ADAS-Cog) in clinical trials. Alzheimers Res Ther. 2015; 7 (1): 1–17.
54. Kirkil G, Tug T, Ozel E, Bulut S, Tekatas A, Muz MH. The evaluation of cognitive functions with p300 test for chronic obstructive pulmonary disease patients in attack and stable period. Clin Neurol Neurosurg. 2007; 109 (7): 553–560.
55. Reeves RR, Struve FA, Patrick G, Payne DK, Thirstrup LL. Auditory and visual p300 cognitive evoked responses in patients with COPD: relationship to degree of pulmonary impairment. Clin Electroencephalogr. 1999; 30 (3): 122–125.
56. Incalzi RA, Gemma A, Marra C, Muzzolon R, Capparella O, Carbonin P. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis. 1993; 148 (2): 418–424.
57. Ott A, Andersen K, Dewey ME, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology. 2004; 62 (6): 920–924.
58. Borson S, Scanlan J, Friedman S, et al. Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis. 2008; 3 (3): 429–434.
59. Lahousse L, Tiemeier H, Ikram MA, Brusselle GG. Chronic obstructive pulmonary disease and cerebrovascular disease: a comprehensive review. Respir Med. 2015; 109 (11): 1371–1380.
60. Urbano F, Mohsenin V. Chronic obstructive pulmonary disease and sleep: the interaction. Panminerva Med. 2006; 48 (4): 223–230.
61. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999; 54 (8): 688–692.
62. Report of the national chronic obstructive pulmonary disease audit: clinical audit of COPD exacerbations admitted to acute NHS units across the UK. 2008; Available from: http://bit.ly/2gLjlGV. Accessed November 23, 2016.
63. Moss M, Franks M, Briggs P, Kennedy D, Scholey A. Compromised arterial oxygen saturation in elderly asthma sufferers results in selective cognitive impairment. J Clin Exp Neuropsychol. 2005; 27 (2): 139–150.
64. Thakur N, Blanc PD, Julian LJ, et al. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis. 2010; 5: 263–269.
65. Antonelli Incalzi R, Marra C, Giordano A, et al. Cognitive impairment in chronic obstructive pulmonary disease-a neuropsychological and spect study. J Neurol. 2003; 250 (3): 325–332.
66. Li J, Fei GH. The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease. Respir Res. 2013; 14: 140.
67. Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012; 186 (3): 240–245.
68. Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest. 2013; 144 (1): 119–127.
69. Chang SS, Chen S, McAvay GJ, Tinetti ME. Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults. J Am Geriatr Soc. 2012; 60 (10): 1839–1846.
70. Ambrosino N, Bruletti G, Scala V, Porta R, Vitacca M. Cognitive and perceived health status in patient with chronic obstructive pulmonary disease surviving acute on chronic respiratory failure: a controlled study. Intensive Care Med. 2002; 28 (2): 170–177.
71. Ozyemisci-Taskiran O, Bozkurt SO, Kokturk N, Karatas GK. Is there any association between cognitive status and functional capacity during exacerbation of chronic obstructive pulmonary disease? Chron Respir Dis. 2015; 12 (3): 247–255.
72. Fix AJ, Daughton D, Kass I, Bell CW, Golden CJ. Cognitive functioning and survival among patients with chronic obstructive pulmonary disease. Int J Neurosci. 1985; 27 (1–2): 13–17.
73. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980; 93 (3): 391–398.
74. Hjalmarsen A, Waterloo K, Dahl A, Jorde R, Viitanen M. Effect of long-term oxygen therapy on cognitive and neurological dysfunction in chronic obstructive pulmonary disease. Eur Neurol. 1999; 42 (1): 27–35.
75. Kozora E, Make BJ. Cognitive improvement following rehabilitation in patients with COPD. Chest. 2000; 117 (5 Suppl 1): 249S [Abstract].
76. Emery CF, Honn VJ, Frid DJ, Lebowitz KR, Diaz PT. Acute effects of exercise on cognition in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164 (9): 1624–1627.
77. Schou L, Ostergaard B, Rasmussen LS, et al. Telemedicine-based treatment versus hospitalization in patients with severe chronic obstructive pulmonary disease and exacerbation: effect on cognitive function. A randomized clinical trial. Telemed J E Health. 2014; 20 (7): 640–646.
78. Bozek A, Krajewska J, Jarzab J. The improvement of cognitive functions in patients with bronchial asthma after therapy. J Asthma. 2010; 47 (10): 1148–1152.
79. Block AJ, Castle JR, Keitt AS. Chronic oxygen therapy. Treatment of chronic obstructive pulmonary disease at sea level. Chest. 1974; 65 (3): 279–288.
80. Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1983; 143 (10): 1941–1947.
81. Dal Negro RW, Bonadiman L, Bricolo FP, Tognella S, Turco P. Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without long-term oxygen therapy (ltot). Multidiscip Respir Med. 2015; 10 (1): 17.
82. Pretto JJ, McDonald CF. Acute oxygen therapy does not improve cognitive and driving performance in hypoxaemic COPD. Respirology. 2008; 13 (7): 1039–1044.
83. Bolton CE, Bevan-Smith EF, Blakey JD, et al. British thoracic society guideline on pulmonary rehabilitation in adults. Thorax. 2013; 68 (Suppl 2): ii1–ii30.
84. Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998; 17 (3): 232–240.
85. Etnier JL, Berry M. Fluid intelligence in an older COPD sample after short-or long-term exercise. Med Sci Sports Exerc. 2001; 33 (10): 1620–1628.
86. Emery CF, Shermer RL, Hauck ER, Hsiao ET, MacIntyre NR. Cognitive and psychological outcomes of exercise in a 1-year follow-up study of patients with chronic obstructive pulmonary disease. Health Psychol. 2003; 22 (6): 598–604.
87. Gregersen TL, Green A, Frausing E, Ringbaek T, Brondum E, Suppli Ulrik C. Do telemedical interventions improve quality of life in patients with COPD? A systematic review. Int J Chron Obstruct Pulmon Dis. 2016; 11: 809–822.
88. Dang V, Medina B, Das D, et al. Formoterol, a long-acting beta2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of down syndrome. Biol Psychiatry. 2014; 75 (3): 179–188.
89. Vanmierlo T, Creemers P, Akkerman S, et al. The pde4 inhibitor roflumilast improves memory in rodents at non-emetic doses. Behav Brain Res. 2016; 303: 26–33.
90. Ray M, Sano M, Wisnivesky JP, Wolf MS, Federman AD. Asthma control and cognitive function in a cohort of elderly adults. J Am Geriatr Soc. 2015; 63 (4): 684–691.
91. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187 (4): 347–365.
92. Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011; 105 (6): 930–938.
93. Taffet GE, Donohue JF, Altman PR. Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging. 2014; 9: 23–30.
94. Quinet P, Young CA, Heritier F. The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease. Ann Phys Rehabil Med. 2010; 53 (2): 69–76.
95. Zarowitz BJ, O’Shea T. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment. J Manag Care Pharm. 2012; 18 (8): 598–606.
96. Dhand R, Dolovich M, Chipps B, Myers TR, Restrepo R, Farrar JR. The role of nebulized therapy in the management of COPD: evidence and recommendations. COPD. 2012; 9 (1): 58–72.
97. Barrons R, Pegram A, Borries A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health Syst Pharm. 2011; 68 (13): 1221–1232.
98. Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J. Guidance on handheld inhalers in asthma and COPD guidelines. Respir Med. 2014; 108 (5): 694–700.
99. Yohannes AM. Management of anxiety and depression in patients with COPD. Expert Rev Respir Med. 2008; 2 (3): 337–347.
100. Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med. 2004; 164 (3): 249–258.
101. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010; 25 (12): 1209–1221.
102. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001; 52 (12): 1615–1620.
103. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2001; 16 (5): 451–454.
104. Memel DS, Kirwan JR, Sharp DJ, Hehir M. General practitioners miss disability and anxiety as well as depression in their patients with osteoarthritis. Br J Gen Pract. 2000; 50 (457): 645–648.
105. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186 (2): 155–161.
106. Sethi JM, Rochester CL. Smoking and chronic obstructive pulmonary disease. Clin Chest Med. 2000; 21 (1): 67–86, viii.
107. Wong ST, Manca D, Barber D, et al. The diagnosis of depression and its treatment in Canadian primary care practices: an epidemiological study. CMAJ Open. 2014; 2 (4): E337–E342.
108. Lu Y, Nyunt MSZ, Gwee X, et al. Life event stress and chronic obstructive pulmonary disease (COPD): associations with mental well-being and quality of life in a population-based study. BMJ open. 2012; 2 (6): e001674.
109. Teixeira PJ, Porto L, Kristensen CH, Santos AH, Menna-Barreto SS, Do Prado-Lima PA. Post-traumatic stress symptoms and exacerbations in COPD patients. COPD. 2015; 12 (1): 90–95.
110. Wiese BS. Geriatric depression: the use of antidepressants in the elderly. BCMJ. 2011; 53 (7): 341–347.
111. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008; 134 (4 Suppl): 43S–56S.
112. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67 (6): 361–370.
113. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988; 56 (6): 893–897.
114. Beck AT, Steer RA, Carbin MG. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988; 8 (1): 77–100.
115. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1995: 722.
116. Di Nardo P, Moras K, Barlow DH, Rapee RM, Brown TA. Reliability of DSM-III-R anxiety disorder categories. Using the anxiety disorders interview schedule-revised (ADIS-R). Arch Gen Psychiatry. 1993; 50 (4): 251–256.
117. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The Prime-MD 1000 study. JAMA. 1994; 272 (22): 1749–1756.
118. Favreau H, Bacon SL, Labrecque M, Lavoie KL. Prospective impact of panic disorder and panic-anxiety on asthma control, health service use, and quality of life in adult patients with asthma over a 4-year follow-up. Psychosom Med. 2014; 76 (2): 147–155.
119. Lavoie KL, Joseph M, Favreau H, et al. Prevalence of psychiatric disorders among patients investigated for occupational asthma: an overlooked differential diagnosis? Am J Respir Crit Care Med. 2013; 187 (9): 926–932.
120. Lavoie KL, Boudreau M, Plourde A, Campbell TS, Bacon SL. Association between generalized anxiety disorder and asthma morbidity. Psychosom Med. 2011; 73 (6): 504–513.
121. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007; 167 (1): 60–67.
122. Papaioannou AI, Bartziokas K, Tsikrika S, et al. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J. 2013; 41 (4): 815–823.
123. Laurin C, Moullec G, Bacon SL, Lavoie KL. The impact of psychological distress on exacerbation rates in COPD. Ther Adv Respir Dis. 2011; 5 (1): 3–18.
124. Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012; 185 (9): 918–923.
125. Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014; 171 (4): 453–462.
126. Dales RE, Spitzer WO, Schechter MT, Suissa S. The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis. 1989; 139 (6): 1459–1463.
127. Liu LY, Coe CL, Swenson CA, Kelly EA, Kita H, Busse WW. School examinations enhance airway inflammation to antigen challenge. Am J Respir Crit Care Med. 2002; 165 (8): 1062–1067.
128. Esler M. The sympathetic system and hypertension. Am J Hypertens. 2000; 13 (6 Pt 2): 99S–105S.
129. Cohen S, Tyrrell DA, Smith AP. Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol. 1993; 64 (1): 131–140.
130. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991; 325 (9): 606–612.
131. O’Leary A. Self-efficacy and health: behavioral and stress-physiological mediation. Cogn Ther Res. 1992; 16 (2): 229–245.
132. Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol. 2003; 24 (8): 444–448.
133. NICE. Depression in adults: recognition and management. Clinical guideline; October 28, 2009. Available from: https://www.nice.org.uk/guidance/cg90/resources/depression-in-adults-recognition-and-management-975742636741. Accessed June 6, 2016.
134. Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 2010; 104 (7): 986–994.
135. Farver-Vestergaard I, Jacobsen D, Zachariae R. Efficacy of psychosocial interventions on psychological and physical health outcomes in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Psychother Psychosom. 2015; 84 (1): 37–50.
136. Smith SM, Sonego S, Ketcheson L, Larson JL. A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease. BMJ Open Respir Res. 2014; 1 (1): e000042.
137. Yohannes AM, Alexopoulos GS. Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes. Drugs Aging. 2014; 31 (7): 483–492.
138. Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Psychosom Res. 2007; 63 (5): 551–565.
139. Alexopoulos GS, Sirey JA, Raue PJ, Kanellopoulos D, Clark TE, Novitch RS. Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. Am J Geriatr Psychiatry. 2006; 14 (5): 466–475.
140. von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest. 2011; 140 (3): 730–736.